FeesSafety
Pluang+

US Treasury yields rise sharply after hotter-than-expected October inflation data.

Market News
10 Nov 2026, 18:37 WIB
CNBC
View Source
Bearish
US Treasury yields rise sharply after hotter-than-expected October inflation data.

US Treasury yields jumped significantly after October's consumer price index (CPI) data showed inflation rising more than economists expected. The 10-year Treasury yield surpassed 5%, reaching 5.004%, while the 30-year yield rose to 5.364%, and the 2-year yield increased to 4.755%. This signals potential for more aggressive Federal Reserve interest rate hikes, possibly extending into 2027, as inflation remains stubborn. Upcoming inflation reports and recent strong employment data will influence the Fed's next moves.

The 10-year US Treasury yield surpassing 5% is the focus, with Pluang market data as of Nov 10, 2026 22:51 WIB showing that out of 150 priced US stocks, 27 rose and 122 fell. Notable movers include LCID (Lucid Group Inc) at USD 4.04 with a 1-day change of +12.22%, UPST (Upstart Holdings Inc) at USD 20.13 down 9.53% but with 100% buy order activity, and PLUG (Plug Power Inc) at USD 1.37 down 8.67% with 72% sell order activity. The most notable figure is LCID's 12.22% gain.

More News

EssilorLuxottica reports total shares and voting rights as of October 31, 2026, with a 31% voting cap per shareholder.

EssilorLuxottica reports total shares and voting rights as of October 31, 2026, with a 31% voting cap per shareholder.

As of October 31, 2026, EssilorLuxottica disclosed its total number of shares at 464,247,548 and actual voting rights at 458,376,127 after deducting treasury shares. The company enforces a 31% voting rights cap per shareholder, as outlined in its sta...

Company Fundamentals
Neutral
1 hour ago
EssilorLuxottica reports 464 million shares and voting rights as of October 31, 2026, with a 31% voting cap.

EssilorLuxottica reports 464 million shares and voting rights as of October 31, 2026, with a 31% voting cap.

EssilorLuxottica disclosed its share capital and voting rights as of October 31, 2026, reporting 464,247,548 shares outstanding and 458,376,127 real voting rights excluding treasury shares. The company applies a 31% cap on voting rights per sharehold...

Company Fundamentals
Neutral
1 hour ago
Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

Peptide therapeutics market to hit $229B by 2036, driven by GLP-1, oncology, and generics growth

The global peptide therapeutics market is projected to grow from $112.2 billion in 2026 to $229.32 billion by 2036, at a CAGR of 7.4%. Growth is fueled by expanding use of GLP-1 and incretin therapies, advances in peptide engineering, new oncology ap...

Bullish
2 hours ago
Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37 named BioSpace 2027 Best Place to Work for innovative clinical trial model and culture

Science 37, a direct-to-patient clinical research site, was named a BioSpace 2027 Best Place to Work, recognized for its innovative culture and commitment to clinical quality. The company’s model brings clinical trials to patients' homes, improving a...

Others
Bullish
2 hours ago
New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

New AI tool Book Leopard cuts Amazon book marketing costs to under $50 with fast, quality covers and ads.

Book Leopard, a new AI software, enables authors and publishers to create professional-quality Amazon book marketing materials in seconds for a one-time fee of $49, drastically reducing costs from over $1,000 and weeks of waiting. The tool generates ...

Others
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App